UPC Universe Pharmaceuticals
- 2.2200
- -0.1800-7.50%
- 2.2204
- +0.0004+0.02%
Universe Pharmaceuticals News
Universe Pharmaceuticals | F-1/A: Registration statement for securities of certain Canadian issuers (Amendment)
Universe Pharmaceuticals | F-1: Registration statement for securities of certain foreign private issuers
Universe Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Universe Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Universe Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Universe Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Universe Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Universe Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Universe Pharmaceuticals | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Universe Pharmaceuticals | NT 20-F: Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F
Universe Pharmaceuticals | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Universe Pharmaceuticals | F-3: Registration statement for specified transactions by certain foreign private issuers
Universe Pharmaceuticals | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Universe Pharmaceuticals | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Universe Pharmaceuticals | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Universe Pharmaceuticals | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Universe Pharmaceuticals | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Universe Pharmaceuticals | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Universe Pharmaceuticals | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Universe Pharmaceuticals | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Analysis
Price Target
No Data
